A patient with poorly controlled diabetes is found to have elevated HbA1c levels, hyperlipidemia, microalbuminuria, diabetic retinopathy, and peripheral neuropathy. What is the nurse's priority intervention to address the patient's immediate risk factors?

D) Collaborate with the healthcare team to adjust the patient's medication regimen for better glucose control.

A) Educate the patient on the importance of a low-sodium diet to manage hypertension.

B) Instruct the patient on proper foot care practices to prevent injuries.

C) Schedule regular ophthalmologic evaluations to monitor diabetic retinopathy.

D) Collaborate with the healthcare team to adjust the patient's medication regimen for better glucose control.

A patient with a history of poorly controlled diabetes presents with elevated HbA1c, LDL cholesterol, and signs of microalbuminuria. Considering the presence of diabetic complications such as retinopathy and neuropathy, which nursing intervention is most critical in the immediate plan of care to prevent further complications?

A) Educate the patient on the importance of regular blood glucose monitoring and adherence to insulin therapy.

B) Schedule an immediate ophthalmologic consultation to address potential visual impairment.

C) Initiate a dietary consultation to reduce LDL cholesterol levels and improve overall nutrition.

D) Provide a comprehensive foot care education session to prevent foot injuries due to neuropathy.

A patient with a history of diabetes and hypertension is on a combination therapy including a GLP-1 receptor agonist and an ACE inhibitor. She presents with orthostatic hypotension, increased fatigue, and a decrease in her eGFR. What would be the most appropriate initial nursing intervention to address her symptoms?

B) Educate the patient on changing positions slowly to prevent dizziness.

A) Advise the patient to increase her fluid intake to manage her blood pressure.

B) Educate the patient on changing positions slowly to prevent dizziness.

C) Recommend the patient to discontinue the ACE inhibitor immediately.

D) Suggest the patient increase her daily sodium intake to counteract hypotension.

A patient with type 2 diabetes has been started on a GLP-1 receptor agonist and an ACE inhibitor. She presents with orthostatic hypotension and a decrease in renal function. What is the most appropriate nursing intervention to address her current symptoms while considering her overall management plan?

A) Increase fluid intake to manage orthostatic hypotension and consult with the healthcare provider about reducing the ACE inhibitor dosage.

B) Discontinue the GLP-1 receptor agonist immediately to see if her symptoms improve.

C) Advise the patient to reduce physical activity until her symptoms resolve and consult with a dietitian about her dietary intake.

D) Schedule the patient for weekly follow-ups to monitor her blood pressure and renal function without adjusting current medication.

A patient with poorly controlled diabetes presents with persistent fatigue, blurred vision, and declining renal function. Her current hemoglobin A1c level is 8.5%, and her eGFR is 45 mL/min/1.73 m². Which nursing intervention is most appropriate to prioritize for this patient?

D) Coordinate with the healthcare provider for potential medication adjustments.

A) Encourage increased physical activity to improve glycemic control.

B) Educate the patient on the importance of adhering to a diabetic diet.

C) Suggest the patient monitor blood glucose levels more frequently.

D) Coordinate with the healthcare provider for potential medication adjustments.

A patient with poorly controlled diabetes and a recent hemoglobin A1c of 8.5% reports fatigue and blurred vision. She has also experienced a decline in renal function with an eGFR of 45 mL/min/1.73 m². In managing this patient, which of the following interventions should the nurse prioritize to address both her glycemic control and renal function?

B) Initiate insulin therapy to achieve better glycemic control.

A) Increase the dose of her current oral hypoglycemic agents.

B) Initiate insulin therapy to achieve better glycemic control.

C) Encourage increased fluid intake to improve kidney perfusion.

D) Recommend strict dietary sodium restriction to protect renal function.

A patient with chronic kidney disease and diabetes presents with increasing lower extremity edema, weight gain, slightly elevated potassium levels, and a recent rise in serum creatinine. Which nursing intervention is most appropriate to address the patient's current condition?

B) Monitor daily weights and assess for signs of fluid overload.

A) Encourage increased fluid intake to promote renal perfusion.

B) Monitor daily weights and assess for signs of fluid overload.

C) Increase dietary potassium intake to balance serum levels.

D) Discontinue the patient's ACE inhibitor to prevent further renal damage.

A patient with diabetes and worsening renal function presents with increased lower extremity swelling, elevated blood pressure, and weight gain. Her lab results indicate elevated serum creatinine and potassium levels, along with proteinuria. Considering these findings, which nursing intervention is most appropriate to address the patient's current condition?

C) Collaborate with the healthcare team to initiate loop diuretic therapy and educate the patient on signs of electrolyte imbalance.

A) Encourage the patient to increase fluid intake to flush out excess potassium.

B) Suggest the patient continue with current dietary sodium restrictions and monitor blood pressure at home.

C) Collaborate with the healthcare team to initiate loop diuretic therapy and educate the patient on signs of electrolyte imbalance.

D) Recommend the patient increase physical activity to promote diuresis and weight loss.

A patient with chronic kidney disease and diabetes presents with increased fatigue, decreased urine output, mild bilateral crackles, and elevated potassium levels. Which of the following nursing interventions is most appropriate to prioritize in this situation?

B) Monitor daily weights and fluid balance to assess for fluid overload

A) Encourage increased dietary potassium intake to support cardiac function

B) Monitor daily weights and fluid balance to assess for fluid overload

C) Administer the prescribed loop diuretic to promote diuresis and manage edema

D) Recommend the patient to continue current medication regimen without adjustments

A patient with chronic kidney disease and diabetes mellitus presents with increased serum creatinine, hyperkalemia, and persistent proteinuria. The healthcare team is considering adjusting the patient's medications. Which nursing intervention is most appropriate to address the patient's elevated potassium levels?

B) Educate the patient on a low-potassium diet to minimize dietary potassium intake.

A) Administer a loop diuretic to enhance potassium excretion.

B) Educate the patient on a low-potassium diet to minimize dietary potassium intake.

C) Encourage increased fluid intake to dilute serum potassium levels.

D) Recommend discontinuation of the ACE inhibitor to reduce potassium retention.

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance – In type 2 diabetes, cells in muscles, fat, and liver become less responsive to insulin, leading to impaired glucose uptake and increased blood sugar levels.

• Secondary mechanism: Impaired insulin secretion – The pancreas' beta cells fail to produce enough insulin in response to blood glucose levels, worsening hyperglycemia.

• Key complication: Chronic hyperglycemia can lead to vascular damage, increasing the risk of cardiovascular disease, nephropathy, and retinopathy.

Patient Profile

Demographics:

58-year-old female, retired school teacher

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 40 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased fatigue and tingling in feet

• Key symptoms: Blurred vision, frequent urination, increased thirst, tingling sensation in feet, occasional dizziness

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, fasting blood glucose 180 mg/dL

Section 1

As the healthcare team continues to assess the patient's condition, new diagnostic results reveal further insights into her health status. A comprehensive metabolic panel shows elevated HbA1c levels at 8.5%, indicating poor long-term glucose control. Additionally, a lipid panel shows LDL cholesterol at 130 mg/dL, which is higher than the target level for a diabetic patient, suggesting increased cardiovascular risk. Urinalysis detects microalbuminuria, a sign of early nephropathy. These findings confirm the presence of diabetic complications affecting multiple organ systems, emphasizing the need for intensified management of her diabetes and associated conditions.

The patient's blurred vision prompts an ophthalmologic evaluation, which uncovers signs of diabetic retinopathy. Retinal imaging shows microaneurysms and cotton wool spots, which suggest that vascular damage has begun to affect her eyes. This finding is consistent with her symptoms and necessitates regular follow-up with an eye specialist to prevent further visual impairment. Meanwhile, the tingling sensation in her feet raises the suspicion of peripheral neuropathy, a common complication of diabetes. A monofilament test reveals decreased sensation in her feet, confirming the diagnosis. This sensory loss increases her risk for foot injuries, highlighting the importance of patient education on foot care and regular podiatric check-ups.

These diagnostic results indicate that the patient's diabetes management plan needs revision. Her current medication regimen may require adjustment or the addition of new therapies to better control her blood glucose levels and prevent further complications. The healthcare team must also address her hypertension and hyperlipidemia more aggressively to mitigate cardiovascular risks. This comprehensive approach will involve collaboration among specialists to tailor a treatment plan that addresses her multifaceted health needs, ultimately aiming to enhance her quality of life and prevent the progression of diabetes-related complications.

Section 2

As the healthcare team implements the revised management plan, the patient is started on a combination therapy that includes a GLP-1 receptor agonist to improve her glycemic control and address her cardiovascular risks. Additionally, her antihypertensive regimen is adjusted to include an ACE inhibitor, aiming to protect her renal function in light of the detected microalbuminuria. Despite these interventions, the patient returns for a follow-up appointment with new complaints of increasing fatigue and occasional dizziness, particularly when rising from a seated position.

Vital signs reveal a blood pressure of 110/70 mmHg while seated, but it drops to 95/60 mmHg upon standing, indicating orthostatic hypotension, a potential side effect of the intensified antihypertensive therapy. Her heart rate is 88 beats per minute, and there are no signs of acute distress or pain. A review of her recent laboratory results shows a further elevation in creatinine levels to 1.4 mg/dL, suggesting a decline in renal function. Electrolyte panels remain within normal limits, but the estimated glomerular filtration rate (eGFR) has decreased to 50 mL/min/1.73 m², warranting close monitoring and possibly necessitating further adjustments to her medication regimen.

These developments necessitate a reevaluation of her current treatment strategy. The healthcare team considers the possibility of reducing her antihypertensive dosage to address her orthostatic symptoms while carefully monitoring her renal function. The integration of a renal specialist into her care team becomes crucial to devise a plan that stabilizes her kidney function without compromising her blood pressure control. Additionally, her fatigue and dizziness are addressed through patient education on gradual position changes and the importance of hydration. The team also emphasizes the need for continued lifestyle modifications, including dietary adjustments and physical activity, to further support her overall health and manage her diabetes more effectively. As her case evolves, regular follow-ups and multidisciplinary collaboration remain central to optimizing her management and preventing further complications.

Section 3

As the healthcare team continues to manage the patient's complex case, they conduct a thorough assessment to better understand her current status and guide further interventions. During this assessment, the patient reports persistent fatigue, which has begun to impact her daily activities and quality of life. She also mentions experiencing episodes of blurred vision, a symptom that had not previously been present. Given these new complaints, the team prioritizes a comprehensive evaluation, including an ocular examination to rule out diabetic retinopathy, a known complication of poorly controlled diabetes.

Further diagnostic testing reveals an elevated hemoglobin A1c level of 8.5%, indicating suboptimal glycemic control despite the current pharmacological regimen. This finding suggests a need to reassess her diabetes management plan, potentially considering additional or alternative therapeutic options to achieve better glycemic outcomes. Concurrently, her renal function continues to be a concern, as her eGFR has further decreased to 45 mL/min/1.73 m². This decline prompts the renal specialist to recommend a more aggressive approach in monitoring her kidney health, including more frequent laboratory evaluations and potential adjustments to her ACE inhibitor dosage.

The team addresses the patient's orthostatic hypotension by advising her to rise slowly from seated or lying positions and ensuring she maintains adequate hydration. They also review her medication regimen, considering a reduction in the dose of her antihypertensive agents to alleviate her symptoms without compromising her cardiovascular protection. As these interventions unfold, the healthcare team prepares for regular follow-up appointments to closely monitor her response, adjusting her care plan as necessary to prevent further complications and enhance her overall well-being. The patient's journey continues with a focus on individualized care and a commitment to multidisciplinary collaboration, ensuring all aspects of her health are comprehensively addressed.

Section 4

One month into the revised management plan, the patient's clinical status begins to exhibit some concerning changes. During a routine follow-up visit, she reports a noticeable increase in swelling of her lower extremities, which has been progressively worsening over the past two weeks. This symptom is accompanied by a weight gain of 4 kilograms, despite her adherence to dietary recommendations aimed at sodium restriction. A physical examination confirms pitting edema in her ankles and lower legs. Her blood pressure is recorded at 150/90 mmHg, slightly elevated compared to previous readings, and her heart rate is 88 beats per minute. These findings raise the suspicion of fluid retention, potentially linked to her declining renal function.

To further investigate, the healthcare team orders a comprehensive metabolic panel and a repeat urinalysis. The results reveal a serum creatinine level that has increased to 2.2 mg/dL from 1.8 mg/dL, and the presence of moderate proteinuria. Additionally, her potassium level is slightly elevated at 5.3 mEq/L. These laboratory findings suggest worsening renal impairment and potentially compromised renal tubular function, necessitating a reassessment of her ACE inhibitor dosage. The renal specialist proposes initiating a loop diuretic to manage her fluid overload while carefully monitoring her electrolytes to prevent hyperkalemia.

The team also evaluates the impact of these developments on her diabetes management, as her glycemic control remains a priority. Her hemoglobin A1c remains elevated at 8.3%, indicating continued challenges in managing her blood glucose levels. The endocrinologist considers adding a sodium-glucose co-transporter-2 (SGLT2) inhibitor to her regimen, given its dual benefits of lowering blood glucose and providing renal protection. This addition requires careful coordination among the healthcare team to manage potential side effects and ensure comprehensive monitoring. The patient's journey thus continues with a renewed focus on optimizing her treatment plan to address both her diabetes and renal challenges, emphasizing the need for vigilant follow-up and collaborative care.

Section 5

Two weeks after the revised treatment plan, the patient returns for a follow-up appointment. During this visit, she reports feeling more fatigued than usual, especially in the afternoons, and has noticed a decrease in her urine output. A physical examination reveals that while the pitting edema in her lower extremities has slightly improved, there is now mild bilateral crackles on lung auscultation, suggesting potential fluid accumulation. Her blood pressure remains elevated at 148/92 mmHg, and her heart rate has increased to 94 beats per minute, indicating a possible compensatory response to her fluid status.

The healthcare team conducts another round of diagnostic tests. The repeat comprehensive metabolic panel shows an increased serum creatinine level of 2.4 mg/dL, worsening from the previous 2.2 mg/dL, and a further rise in potassium levels to 5.6 mEq/L. The proteinuria persists, indicating ongoing renal impairment. These lab results, coupled with the clinical findings, suggest that while the loop diuretic has partially alleviated peripheral edema, it has not adequately managed her overall fluid balance and renal function.

In response to these developments, the team considers adjusting her treatment strategy. The risk of hyperkalemia is increasingly concerning, prompting a reevaluation of her medications, particularly the ACE inhibitor and the recently added SGLT2 inhibitor. The nephrologist suggests introducing a potassium binder to help control her serum potassium levels. Simultaneously, the endocrinologist emphasizes the need to refine her diabetes management, potentially by adjusting her insulin regimen to improve glycemic control without exacerbating her renal condition. This evolving clinical scenario underscores the complexity of her case, necessitating ongoing, multidisciplinary collaboration to optimize outcomes and prevent further complications.